Effect of Post-Transplant Cyclophosphamide as Graft-versus-Host Disease Prophylaxis in Allogeneic Stem Cell Transplant

Authors

• Mikayla Baker, St. John Fisher University
• Heather McGrane Minton, St. John Fisher UniversityFollow

Document Type

Conference Proceeding

Publication Date

3-2026

Abstract

Graft-versus-host disease (GVHD), a complication related to allogeneic stem cell transplant, may be prevented by post-transplant cyclophosphamide (PTCy). There is a gap in understanding how patients with acute myeloid leukemia (AML) receiving different subtypes of allogeneic stem cell transplants respond to PTCy.

The purpose was to determine if subtypes of allogeneic stem cell transplants differ in GVHD, engraftment, and relapse for patients with AML, treated with PTCy.

Comments

Presented at 38th Annual Scientific Sessions of the Eastern Nursing Research Society, March 25-27, 2026

Publication Information

Baker, Mikayla and McGrane Minton, Heather, "Effect of Post-Transplant Cyclophosphamide as Graft-versus-Host Disease Prophylaxis in Allogeneic Stem Cell Transplant" (2026). Nursing Faculty/Staff Publications. Paper 224.
https://fisherpub.sjf.edu/nursing_facpub/224

Please note that the Publication Information provides general citation information and may not be appropriate for your discipline. To receive help in creating a citation based on your discipline, please visit https://libguides.sjf.edu/citations.